FDA Import Refusal 799-4765877-0/11/3 — Aimil Pharmaceuticals India
The FDA refused shipment 799-4765877-0/11/3 from Aimil Pharmaceuticals India (India) on Dec 18, 2024. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 18, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA99 ANTI-DIABETIC N.E.C.
- Charges
- 75